Business

Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia

Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia Canada New...

articleAurora Cannabis Inc.March 4, 20243/company/aurora-cannabis-inc/news/aurora-introduces-medical-cannabis-pastilles-for-patient-relief-in-australia
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia

About this update from Aurora Cannabis Inc.

[{"type":"text","content":"\n \n \n \n Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n NASDAQ | TSX: ACB\n \n \n \n \n Canada's\n \n Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients\n \n \n \n \n \n EDMONTON, AB\n \n \n ,\n \n \n March 4, 2024\n \n \n /CNW/ -\n \n Aurora Cannabis Inc.\n \n (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in\n \n Australia\n \n . The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.\n \n \n \n \n \n \n \n \n \n \"\n \n Australia\n \n is the largest nationally legal medical market globally, and as a long-standing supplier to MedReleaf Australia and recently announced parent company, we're eager to support the continued growth and development of the market,\" said\n \n Andre Jerome\n \n , Executive Vice President of Global Business Development, Aurora. \"The introduction of innovative and differentiated products, such as pastilles, and planned upcoming innovation, will provide Australian doctors expanded options for patient care and enhance patient access to the premium medical cannabis they seek,\" continued Jerome.\n \n \n The 30-pack pastilles are available now in three formats including:\n \n \n \n Aurora THC Pastilles in Watermelon flavour (5mg THC)\n \n \n Aurora CBD Pastilles in Peach flavour (10mg CBD)\n \n \n Aurora Balanced Pastilles in Yuzu Lemon flavour (5mg THC, 10mg CBD)\n \n \n \n MedReleaf Australia is committed to providing Australian patients with a consistent and reliable supply of superior quality products, including dried flower, resin cartridges and oils, and now p...

More updates from Aurora Cannabis Inc.